| Kimberly Nan Palkert, DPT | |
|
14884 Kirkwood Dr, Baxter, MN 56425-8451 | |
| (218) 824-5027 | |
| (218) 824-8011 |
| Full Name | Kimberly Nan Palkert |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 14884 Kirkwood Dr, Baxter, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164205621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 11521 (Minnesota) | Primary |
| Provider Name | Select Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1033103742 PECOS PAC ID: 3577566496 Enrollment ID: O20060815000351 |
News Archive
Federal funding of human embryonic stem cell (hESC) research is now legal in the United States. Chief judge of the US District Court for the District of Columbia Royce Lamberth has ruled on the case Sherley et al. v. Sebelius, in favor of hESC research. This overturns an existing law that prohibits the government from funding research that destroys the embryo.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
Virginia Commonwealth University has received a $3 million grant from the National Institute of Mental Health to study key molecular markers found in DNA that predict chronic depression.
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 4 days ago
| Provider Name | Select Urgent Care Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1952063158 PECOS PAC ID: 1658762646 Enrollment ID: O20211230000768 |
News Archive
Federal funding of human embryonic stem cell (hESC) research is now legal in the United States. Chief judge of the US District Court for the District of Columbia Royce Lamberth has ruled on the case Sherley et al. v. Sebelius, in favor of hESC research. This overturns an existing law that prohibits the government from funding research that destroys the embryo.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
Virginia Commonwealth University has received a $3 million grant from the National Institute of Mental Health to study key molecular markers found in DNA that predict chronic depression.
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly Nan Palkert, DPT 14884 Kirkwood Dr, Baxter, MN 56425-8451 Ph: (218) 824-5027 | Kimberly Nan Palkert, DPT 14884 Kirkwood Dr, Baxter, MN 56425-8451 Ph: (218) 824-5027 |
News Archive
Federal funding of human embryonic stem cell (hESC) research is now legal in the United States. Chief judge of the US District Court for the District of Columbia Royce Lamberth has ruled on the case Sherley et al. v. Sebelius, in favor of hESC research. This overturns an existing law that prohibits the government from funding research that destroys the embryo.
Acceleron Pharma Inc., a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today reported that Acceleron, Celgene and investigators in the sotatercept and ACE-536 phase 2 clinical trials will give three oral presentations of interim data from ongoing studies in beta-thalassemia and myelodysplastic syndromes as well as a poster presentation of nonclinical data in sickle cell disease at the 19th Annual Congress of the European Hematology Association (EHA) in Milan, Italy from June 12-15, 2014.
Virginia Commonwealth University has received a $3 million grant from the National Institute of Mental Health to study key molecular markers found in DNA that predict chronic depression.
Bacteria lurking in the water lines at the dentist's office are tougher than we thought, according to a new paper published in Water Research. The study reveals that the disinfectants recommended by companies that manufacture the water lines don't actually shift all the bacteria in the lines, which means they're never completely clean.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
› Verified 4 days ago
Elizabeth Kae Hermanson, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 14884 Kirkwood Dr, Baxter, MN 56425 Phone: 218-824-5027 | |
Select Therapy, Inc. Physical Therapist Medicare: Medicare Enrolled Practice Location: 14884 Kirkwood Drive, Baxter, MN 56425 Phone: 218-824-5027 Fax: 218-824-8011 | |
Meredith Hillary Maria Griffin, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7350 Clearwater Rd, Baxter, MN 56425 Phone: 218-454-5050 | |
Justin Woitte, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-2880 | |
Travis Beniak, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 13060 Isle Dr, Baxter, MN 56425 Phone: 218-828-2880 | |
Big Stone Therapies Baxter, Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 15620 Edgewood Dr, Suite 240, Baxter, MN 56425 Phone: 218-454-7012 Fax: 218-454-7015 |